Suggestions
Lorna Neilson
Life Science Executive - VP, Corporate Development at Takara Bio USA, Inc.
Lorna Neilson: Bridging Science and Business
Lorna Neilson is an exceptional molecular biologist with a remarkable talent for translating life science technologies into innovative products that can improve health and overall quality of life. With a deep-seated passion for science and its commercialization, Lorna specializes in connecting scientific breakthroughs with clinical applications, ensuring that cutting-edge technologies reach the marketplace effectively. Her forward-thinking approach enables her to identify pioneering advancements, particularly in genetic analysis, making her an invaluable asset to any organization aiming for expansion and success in this fast-evolving industry.
Professional Background
With a diverse career spanning various roles including strategist, entrepreneur, corporate and business development leader, and general manager, Lorna Neilson has donned many hats throughout her professional journey. Recently, she has taken on the role of Vice President of Corporate Development at Takara Bio USA, Inc., where she leads the company's strategic expansion into reproductive health testing and other clinical markets. By harnessing whole genome amplification and next-generation sequencing (NGS) technologies, her team is dedicated to advancing low input and single-cell analysis methodologies, along with enhancing their broad portfolio that includes PCR enzymes and stem cell products.
Lorna’s extensive experience in managing contracts and legal transactions is a significant factor in her role, where she oversees technology acquisitions through in-licensing and mergers and acquisitions (M&A), while also managing all out-licensing and OEM transactions. Her ability to navigate complex problems and lead multidisciplinary teams has resulted in successful outcomes in various corporate initiatives.
Education and Achievements
Lorna’s educational background is equally impressive, having pursued her postdoctoral fellowship at the esteemed University of California, San Diego. She also earned her Doctor of Philosophy (PhD) degree from the University of Southern California, where she gained critical insights into molecular biology and genomics. In addition to her doctoral studies, she possesses a Bachelor of Arts (BA) degree from California State University, Northridge, underscoring her solid foundational knowledge in the sciences.
Throughout her career, Lorna has held a range of impressive positions at various prestigious companies. Prior to her current position, she served as Senior Vice President of Business Development and Marketing at RiboMed Biotechnologies, Inc., where she acted as a consultant. Her entrepreneurial spirit was evident during her time as Principal and Founder of inGENEuity Life Science Group, LLC, where she provided valuable insights and guidance to clients in the life sciences sector.
Notably, Lorna was previously the Senior Director of Marketing at Sequenom, a well-known leader in genetic analysis and testing. She also played significant roles at Life Technologies, where she was Director of Licensing, Director of Business Development, Global Head of BioDiscovery Services, and General Manager of the Sequitur Subsidiary Site/RNAi Business Integration. Her depth of experience at Life Technologies, a recognized name in the field of biotechnology, has equipped her with an in-depth understanding of the genomic and diagnostic landscape.
Specialties and Skills
Lorna Neilson's professional expertise is vast and varied, encompassing a multitude of specialties that are critical in the contemporary biotech and life sciences markets. Her core competencies include:
- Leadership: Lorna excels in guiding teams through complex projects, ensuring alignment with corporate strategy and objectives.
- Corporate Development and Business Development: With her extensive experience in corporate settings, Lorna effectively leads initiatives that drive growth and innovation.
- Licensing and IP Management: Her proficiency in managing intellectual property ensures that her organizations maximize their technological assets.
- Mergers & Acquisitions: Lorna plays a key role in driving successful M&A transactions, ensuring the smooth integration of businesses and technologies.
- New Product Development and Launch: She is adept at taking products from concept to market, utilizing her knowledge of market research and strategic planning.
- Contract Negotiation: Her negotiation skills are pivotal in securing beneficial agreements that support business development.
- Cross-Functional Team Building: Lorna's ability to foster collaborations among diverse teams enhances innovation and problem-solving.
- International Business: Lorna has a global perspective, making her well-suited to navigate international markets and collaborations.
- Genomics and Transcriptomics: Her deep knowledge in these areas positions her as a thought leader and influencer in biotech.
- Reproductive Health Testing and Single-Cell Sequencing: These emerging fields are part of her strategic focus to drive company expansion.
Notable Contributions
Lorna's contributions to the life sciences industry are profound and far-reaching. She has successfully guided companies in recognizing and capitalizing on emerging trends within molecular biology and genomics. Her strategic insights have driven the launch of several innovative products that are now pivotal in clinical applications, particularly in reproductive health.
Moreover, Lorna has established collaborative partnerships that further the goals of her organizations while advancing scientific research and discovery. She is dedicated to ensuring that groundbreaking technologies reach those who need them the most, making significant contributions to public health and scientific advancement.
Conclusion
Lorna Neilson is a dynamic and accomplished professional whose passion for integrating science with business has led to impressive career achievements. With her extensive background in molecular biology, corporate development, and strategic management, she embodies the spirit of innovation that the life sciences industry needs to succeed. As the landscape of health and biotechnology continues to evolve, Lorna remains at the forefront, continuously seeking to improve health outcomes and enhance the quality of life through her work in technology commercialization and strategic leadership.
